Please assess the completion status of the following clinical trial:

Trial Title: Effects of Proprioceptive Focal Stimulation (EQUISTASI) on Freezing of Gait in Parkinson's Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patient with Parkinson's Disease~* Stable drug therapy response without any change in the 3 months before the study.~* written informed consent~Exclusion Criteria:~* Hoehn-Yahr stage ≥ 4~* Cognitive decline (Mini Mental State Examination \<26)~* Systemic illness involving the nervous system~* Diabetes~* Presence of cardiac pacemaker~* Presence of deep brain stimulation~* Presence of severe dysautonomia with marked hypotension~* History or active neoplasia~* Pregnancy

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- EQUISTASI (Type: EXPERIMENTAL): Equistasi is a nanotechnology for proprioceptive focal stimulation. Every patient will receive four patches to be placed on both legs for 4 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).